Contact: Karen Kreeger
University of Pennsylvania School of Medicine
Caption: This is an invasive stage lesion from the human PDAC-iPS line grown in immune-tolerant mice for 9 months.
Credit: Kenneth Zaret, PhD, Perelman School of Medicine, University of Pennsylvania
Usage Restrictions: None
Related news release: Pluripotent cells from pancreatic cancer cells first human model of cancer's progression